Naturally-occurring β-glucans are mostly investigated for their antitumor activity and immunomodulatory property. They have been widely regarded as a natural source for functional foods and pharmaceuticals. However, the physico-chemically stable and biocompatible properties of β-glucans are rarely explored as a coating material for nanomaterials to overcome the problems of aggregation and cytotoxicity. This article reviews on the exploration of β-glucans, in particular those derived from mushrooms, as a natural coating material to modify the surface properties of bioactive substances as a relatively simple and cost-effective strategy to produce stable and biocompatible nanohybrids used for biopharmaceutical use. It is envisaged that such β-glucan-based coating method will provide new opportunities to design biocompatible functional nanomaterials for wider clinical applications.
No takes yet. Share an insight, caveat, or question.
Li et al. (2019) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: